
Keywords: BNab; broadly neutralising antibody; CTL; cytotoxic lymphocyte; DAA; direct-acting antiviral; HBV; hepatitis B virus; HCV; hepatitis C virus; HIV; human immunodeficiency virus; NGS; next generation sequencing; SGA; single genome amplification; SNP; single